A photoactivatable and phenylboronic acid-functionalized nanoassembly for combating multidrug-resistant gram-negative bacteria and their biofilms

被引:8
|
作者
Zhou, Xiaoqing [1 ]
Dong, Lanlan [2 ]
Zhao, Baohua [2 ]
Hu, Guangyun [2 ]
Huang, Can [2 ]
Liu, Tengfei [3 ]
Lu, Yifei [2 ]
Zheng, Mengxue [1 ]
Yu, Yanlan [1 ]
Yang, Zengjun [1 ]
Cheng, Shaowen [4 ]
Xiong, Yan [5 ]
Luo, Gaoxing [2 ]
Qian, Wei [2 ]
Yin, Rui [1 ]
机构
[1] Army Med Univ Third Mil Med Univ, Southwest Hosp, Dept Dermatol, 29 Gaotanyan Rd, Chongqing 400038, Peoples R China
[2] Army Med Univ Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burn & Combined Injury, 29 Gaotanyan Rd, Chongqing 400038, Peoples R China
[3] 906 Hosp Joint Logist Support Force PLA, Dept Burn & Plast Sugery, 377 Zhongshan East Rd, Ningbo 315100, Peoples R China
[4] Hainan Med Univ, Dept Wound Repair, Affiliated Hosp 1, 31 Longhua Rd, Haikou 570102, Hainan, Peoples R China
[5] Army Med Univ Third Mil Med Univ, Daping Hosp, Dept Orthopaed, 10 Changjiang Branch Rd, Chongqing 400042, Peoples R China
基金
中国国家自然科学基金;
关键词
Photothermal therapy; Photodynamic therapy; Nitric oxide; Synergistic; Boronic acid; Multidrug-resistant gram-negative bacteria; NITRIC-OXIDE; NANOWORMS; MEMBRANE;
D O I
10.1093/burnst/tkad041
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Multidrug-resistant (MDR) gram-negative bacteria-related infectious diseases have caused an increase in the public health burden and mortality. Moreover, the formation of biofilms makes these bacteria difficult to control. Therefore, developing novel interventions to combat MDR gram-negative bacteria and their biofilms-related infections are urgently needed. The purpose of this study was to develop a multifunctional nanoassembly (IRNB) based on IR-780 and N, N'-di-sec-butyl-N, N'-dinitroso-1,4-phenylenediamine (BNN6) for synergistic effect on the infected wounds and subcutaneous abscesses caused by gram-negative bacteria. Methods: The characterization and bacteria-targeting ability of IRNB were investigated. The bactericidal efficacy of IRNB against gram-negative bacteria and their biofilms was demonstrated by crystal violet staining assay, plate counting method and live/dead staining in vitro. The antibacterial efficiency of IRNB was examined on a subcutaneous abscess and cutaneous infected wound model in vivo. A cell counting kit-8 assay, Calcein/PI cytotoxicity assay, hemolysis assay and intravenous injection assay were performed to detect the biocompatibility of IRNB in vitro and in vivo. Results: Herein, we successfully developed a multifunctional nanoassembly IRNB based on IR-780 and BNN6 for synergistic photothermal therapy (PTT), photodynamic therapy (PDT) and nitric oxide (NO) effect triggered by an 808 nm laser. This nanoassembly could accumulate specifically at the infected sites of MDR gram-negative bacteria and their biofilms via the covalent coupling effect. Upon irradiation with an 808 nm laser, IRNB was activated and produced both reactive oxygen species (ROS) and hyperthermia. The local hyperthermia could induce NO generation, which further reacted with ROS to generate ONOO-, leading to the enhancement of bactericidal efficacy. Furthermore, NO and ONOO- could disrupt the cell membrane, which converts bacteria to an extremely susceptible state and further enhances the photothermal effect. In this study, IRNB showed a superior photothermal-photodynamic-chemo (NO) synergistic therapeutic effect on the infected wounds and subcutaneous abscesses caused by gram-negative bacteria. This resulted in effective control of associated infections, relief of inflammation, promotion of re-epithelization and collagen deposition, and regulation of angiogenesis during wound healing. Moreover, IRNB exhibited excellent biocompatibility, both in vitro and in vivo. Conclusions: The present research suggests that IRNB can be considered a promising alternative for treating infections caused by MDR gram-negative bacteria and their biofilms.
引用
收藏
页数:27
相关论文
共 50 条
  • [21] Flavomycin restores colistin susceptibility in multidrug-resistant Gram-negative bacteria
    Huang, Ying
    Zhu, Yan
    Yue, Hui-Ying
    Liu, Yi-Yun
    Deng, Li-Min
    Lv, Luchao
    Wang, Chengzhen
    Yang, Jun
    Liu, Jian-Hua
    MSYSTEMS, 2024, 9 (06)
  • [22] Trends of 9,416 multidrug-resistant Gram-negative bacteria
    Colombo Oliveira, Viviane Decicera
    Rubio, Fernando Gongora
    Gottardo Almeida, Margarete Teresa
    Lelles Nogueira, Mara Correa
    Campos Pignatari, Antonio Carlos
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2015, 61 (03): : 244 - 249
  • [23] Multidrug-Resistant Gram-Negative Bacteria Infections in Solid Organ Transplantation
    van Duin, D.
    van Delden, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 31 - 41
  • [24] Potent Antibiotics Active against Multidrug-Resistant Gram-Negative Bacteria
    Otsuka, Yasunari
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2020, 68 (03) : 182 - 190
  • [25] Cefiderocol, a new antibiotic against multidrug-resistant Gram-negative bacteria
    Tiago Silva, Jose
    Lopez-Medrano, Francisco
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2021, 34 : 41 - 43
  • [26] Prevalence of Oxacillinase Genes in Clinical Multidrug-Resistant Gram-Negative Bacteria
    Ahmed, Omar B.
    Bamaga, Majid A.
    CLINICAL LABORATORY, 2025, 71 (03) : 465 - 471
  • [27] Moroccan Hospital Cockroaches: Carriers of Multidrug-Resistant Gram-Negative Bacteria
    Dihmane, Asmaa
    Aniba, Rafik
    Raqraq, Habiba
    Ressmi, Amina
    Chouati, Taha
    Abi, Oussama
    El Fahime, El Mostafa
    Nayme, Kaotar
    Timinouni, Mohammed
    Barguigua, Abouddihaj
    ECOHEALTH, 2025,
  • [28] Multidrug-Resistant Gram-Negative Bacteria Infection Prevention and Control Update
    Mills, John P.
    Marchaim, Dror
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2021, 35 (04) : 969 - 994
  • [29] Ceftazidime-avibactam in the treatment of multidrug-resistant Gram-negative bacteria
    不详
    LANCET INFECTIOUS DISEASES, 2016, 16 (06): : 646 - 647
  • [30] Cefiderocol: a promising antibiotic against multidrug-resistant Gram-negative bacteria
    Jean, Shio-Shin
    Hsueh, Shun-Chung
    Lee, Wen-Sen
    Hsueh, Po-Ren
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2019, 17 (05) : 307 - 309